Today's Change
+0%
AI Sentiment
55%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0% today with neutral sentiment across 5 recent news articles.
Bullish Factors
- Predominantly positive news flow
Risk Factors
- No strong bearish signals detected
Stocks in Materials
0 stocks| Symbol | Company | Change |
|---|
Materials News
926 articles
GlobeNewswire Inc.79d ago
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
GlobeNewswire Inc.79d ago
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
GlobeNewswire Inc.79d ago
RARE DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE
The Motley Fool79d ago
TMC Stock Is Up With Retail Investors as the U.S. and Japan Team Up to Challenge China's Grip on Critical Minerals
The Motley Fool79d ago
The Metals Company Inc. Just Got Incredible News from the NOAA. Here's What It Means for Investors.
The Motley Fool79d ago
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?
GlobeNewswire Inc.80d ago
ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
The Motley Fool80d ago
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.
The Motley Fool80d ago
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
GlobeNewswire Inc.80d ago
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
GlobeNewswire Inc.80d ago
QURE 9-DAY DEADLINE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data
GlobeNewswire Inc.81d ago
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
Market Sentiment
Neutral
55% Sentiment Score
Sector Stats
Total Stocks0
News Today5
Avg Volume0
AI SentimentNeutral